Elevated Pre-operative D-Dimer Levels Do Not Impact the Effect of Tranexamic Acid on Revision Total Knee Arthroplasty

Orthop Clin North Am. 2022 Apr;53(2):139-143. doi: 10.1016/j.ocl.2021.12.001. Epub 2022 Mar 7.

Abstract

The purpose of this study was to determine if elevated pre-operative D-dimer levels in patients undergoing revision total knee arthroplasty (rTKA) pose an increased risk of: (1) post-operative venous thromboemboli (VTE); (2) intra-operative blood loss; and (3) need for transfusion of blood products. Eighty-nine patients who underwent rTKA by a single surgeon between January 1, 2017, and December 31, 2019, met the inclusion criteria. Elevated pre-operative D-dimer levels did not pose an increased risk of VTE, blood loss, or transfusion of blood products, demonstrating that elevated pre-operative D-dimer is not a contraindication to the use of tranexamic acid for rTKA.

Keywords: D-dimer; Revision total knee arthroplasty; TXA; Tranexamic acid; rTKA.

Publication types

  • Review

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Arthroplasty, Replacement, Knee* / adverse effects
  • Fibrin Fibrinogen Degradation Products
  • Humans
  • Tranexamic Acid* / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Tranexamic Acid